Back
Regeneron Pharmaceuticals Stock Price Chart
Fed rate cuts could send the stock market down
Here's my #1 free indicator to use now.
Buy
62
REGN
Regeneron Pharmaceuticals
Last Price:
1,131.54
Seasonality Move:
5.36%
7 Day Trial
ALL ACCESS PASS
$
7
Wall St. Icon: Looming Financial Tsunami Could Wipe Out the 1%
Click here to see his new prediction.- The current trend is moderately bearish and REGN is experiencing selling pressure, which indicates risk of future bearish movement.
Regeneron Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1174.56 | Sell |
| 20-day SMA: | 1173.99 | Sell |
| 50-day SMA: | 1110.97 | Buy |
| 200-day SMA: | 979.87 | Buy |
| 8-day EMA: | 1165.61 | Sell |
| 20-day EMA: | 1160.33 | Sell |
| 50-day EMA: | 1117.98 | Buy |
| 200-day EMA: | 995.44 | Buy |
Regeneron Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 15.83 | Buy |
| Relative Strength Index (14 RSI): | 44.04 | Sell |
| Chaikin Money Flow: | -319679 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1111.26 - 1199.2) | Sell |
| Bollinger Bands (100): | (954.76 - 1129.72) | Buy |
Regeneron Pharmaceuticals Technical Analysis
| Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Regeneron Pharmaceuticals Stock
Is Regeneron Pharmaceuticals Stock a Buy?
- Regeneron Pharmaceuticals share price is 1,131.75 while REGN 8-day simple moving average is 1,174.56, which is a Sell signal.
- The stock price of REGN is 1,131.75 while Regeneron Pharmaceuticals 20-day SMA is 1,173.99, which makes it a Sell.
- Regeneron Pharmaceuticals 50-day simple moving average is 1,110.97 while REGN share price is 1,131.75, making it a Buy technically.
- REGN stock price is 1,131.75 and Regeneron Pharmaceuticals 200-day simple moving average is 979.87, creating a Buy signal.
REGN Technical Analysis vs Fundamental Analysis
Buy
62
Regeneron Pharmaceuticals (REGN)
is a Buy
Is Regeneron Pharmaceuticals a Buy or a Sell?
-
Regeneron Pharmaceuticals stock is rated a Buy
The current Regeneron Pharmaceuticals [REGN] share price is $1,131.75. The Score for REGN is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
Regeneron Pharmaceuticals Stock Info
Market Cap:
124.76B
Price in USD:
1,131.75
Share Volume:
416.45K
Regeneron Pharmaceuticals 52-Week Range
52-Week High:
1,211.20
52-Week Low:
769.19
Buy
62
Regeneron Pharmaceuticals (REGN)
is a Buy
Regeneron Pharmaceuticals Share Price Forecast
-
What is the Regeneron Pharmaceuticals stock price today?
The Regeneron Pharmaceuticals stock price is 1,131.75 USD today. -
Will REGN stock go up or go down?
Regeneron Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Regeneron Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Regeneron Pharmaceuticals is not overvalued.
Is Regeneron Pharmaceuticals Stock a Buy?
- Regeneron Pharmaceuticals share price is 1,131.75 while REGN 8-day exponential moving average is 1,165.61, which is a Sell signal.
- The stock price of REGN is 1,131.75 while Regeneron Pharmaceuticals 20-day EMA is 1,160.33, which makes it a Sell.
- Regeneron Pharmaceuticals 50-day exponential moving average is 1,117.98 while REGN share price is 1,131.75, making it a Buy technically.
- REGN stock price is 1,131.75 and Regeneron Pharmaceuticals 200-day simple moving average is 995.44, creating a Buy signal.
Fundamental Analysis of Regeneron Pharmaceuticals
Is Regeneron Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.99 per share, an increase next quarter of $1.60 per share, an increase this year of $2.54 per share, and an increase next year of $3.85 per share.
Technical Analysis of Regeneron Pharmaceuticals
Should I short Regeneron Pharmaceuticals stock?
- REGN Moving Average Covergence Divergence (MACD) indicator is 15.83, suggesting Regeneron Pharmaceuticals is a Buy
- Regeneron Pharmaceuticals Relative Strength Index (RSI) is 44.04, which suggest Regeneron Pharmaceuticals is oversold
- The Bollinger Bands (25) for Regeneron Pharmaceuticals is (1111.26 - 1199.2), which suggest Regeneron Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Regeneron Pharmaceuticals is (954.76 - 1129.72), which suggest Regeneron Pharmaceuticals is a Buy
* Regeneron Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.